⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

DHR

Danaher Corporation

Healthcare · Diagnostics & Research

204.85USD

-0.3800 (-0.19%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24
Revenue6,2655,9516,8386,0535,9365,7416,5385,798
Cost of Revenue2,6542,3602,8722,5302,4132,2302,6482,397
Gross Profit3,6113,5913,9663,5233,5233,5113,8903,401
Operating Income1,1271,3441,5021,1547601,2741,425958
Net Income8701,0291,1979085559541,086818
EPS (Diluted)$1.23$1.45$1.68$1.27$0.77$1.32$1.49$1.12

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)